NCT04124406Active, not recruiting
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
Source: ClinicalTrials.gov · Last updated 3 Oct 2025
Brief summary (registry, in English)
The purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 150000 (estimated)
- First submitted
- 10 Oct 2019
- Start date
- 18 Oct 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Exact Sciences Corporation
- Diseases
- Colorectal cancer
- NCT number
- NCT04124406
What you commit to
- Study type: Observational
- Planned participants: 150000
- From 18 Oct 2019 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- N/A
Who the study is looking for
- Resident of the United States
- Age 18 years or older
- Able to provide informed consent
- Able to complete surveys in English or Spanish
- Valid order for Cologuard screening
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.